Clayton Financial Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40
Closed -$13 78
2026
Q1
$13 Hold
40
﹤0.01% 614
2025
Q4
$689 Hold
40
﹤0.01% 573
2025
Q3
$1.03K Buy
+40
New +$1.51K ﹤0.01% 271

Other funds holding AGL

Clayton Financial Group's AGL Position: Q2 2026 in Review

Clayton Financial Group sold out of Agilon Health (AGL) in Q2 2026, closing a stake of 40 shares — an estimated $13 sold.

Clayton Financial Group first reported a position in AGL in Q3 2025 and held it in 3 quarters. The position peaked at $1.03K in Q3 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Clayton Financial Group reported no remaining Agilon Health position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 40 Agilon Health shares in Q2 2026, an estimated $13.
  • Clayton Financial Group first reported a position in Agilon Health in Q3 2025 and held it in 3 quarters.
  • Clayton Financial Group's Agilon Health position peaked at $1.03K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.